Mesenchymal Stem Cell Research
84 researchers across 8 institutions
Mesenchymal stem cells (MSCs) are a focus of study for their potential therapeutic applications. Research explores the fundamental biology of MSCs, including their self-renewal capabilities, differentiation into various cell types like bone, cartilage, and fat, and their immunomodulatory properties. Investigations employ techniques such as cell culture, genetic manipulation, and imaging to understand how MSCs interact with their microenvironment and respond to different stimuli. Specific areas of inquiry include harnessing MSCs for tissue repair and regeneration, developing novel cell-based therapies for diseases, and understanding the molecular mechanisms that govern MSC function.
This research holds significant relevance for Arkansas. The state's aging population and high rates of chronic diseases like diabetes and cardiovascular conditions underscore the need for advanced regenerative medicine strategies. MSC research offers pathways to develop new treatments that could improve public health outcomes and reduce healthcare burdens. Furthermore, advancements in this field can foster innovation within Arkansas's growing biotechnology and biopharmaceutical sectors, potentially creating new economic opportunities and high-skill jobs.
Work in this area frequently intersects with tissue engineering, cancer biology, nanotechnology, and pharmacology. This research is conducted across multiple Arkansas institutions, fostering collaboration and a broad base of expertise in stem cell science and its applications.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Robert J. Griffin | UAMS | 71 | 25,813 | Grant PI High Impact | |
| Shmuel Yaccoby | UAMS | 46 | 8,087 | High Impact | |
| Nadine Hempel | UAMS | 39 | 4,929 | ||
| Shi‐Ming Tu | UAMS | 36 | 5,059 | High Impact | |
| Timothy C. Chambers | UAMS | 35 | 4,667 | High Impact | |
| Robert Griffin | UAMS | 34 | 4,665 | Grant PI High Impact | |
| Jin-Woo Kim | University of Arkansas | 31 | 4,243 | High Impact Grants | |
| Neriman Gökden | UAMS | 29 | 2,867 | High Impact | |
| Fei Jia | University of Arkansas | 28 | 2,658 | High Impact | |
| Zhan Su | UAMS | 28 | 15,963 | High Impact | |
| Raj R. Rao | University of Arkansas | 27 | 2,671 | Grant PI High Impact | |
| Malliga Raman Murali | UAMS | 27 | 1,790 | High Impact | |
| Shawn E. Bourdo | UA Little Rock | 26 | 2,259 | High Impact | |
| Zhiqiang Qin | UAMS | 25 | 1,830 | High Impact | |
| Qiang Fu | UAMS | 24 | 2,878 | High Impact | |
| Elisabeth Ferreira | UAMS | 22 | 1,656 | High Impact | |
| Rebekah M. Samsonraj | University of Arkansas | 22 | 2,269 | High Impact | |
| John Talpos | NCTR | 21 | 1,625 | High Impact | |
| Min Zou | University of Arkansas | 21 | 1,730 | ||
| Fatemeh Moradi | UAMS | 21 | 1,472 | High Impact |
Related Research Areas
Connected Research Areas
Topics that share active collaborators with Mesenchymal Stem Cell Research in Arkansas. Pairs are ranked by collaboration density relative to expected co-authorship under a random null. This describes existing connections, not investment recommendations.
- Nanoparticles: synthesis and applications
- Tissue Engineering and Regenerative Medicine
- Orthopedic Surgery and Rehabilitation
- Biomedical and Engineering Education
- Host-Pathogen Interactions
- Health Literacy and Information Accessibility
- Cancer-related molecular mechanisms research
- Drug Delivery Systems
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Harvard University 1,484
- 2 Stanford University 1,242
- 3 University of Pittsburgh 933
- 4 Johns Hopkins University 909
- 5 University of Michigan 731
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Mesenchymal Stem Cell Research.